Emergence of macrolide resistant Streptococcus pyogenes strains in pediatric patients in France
A total of 206 recent throat isolates of Streptococcus pyogenes collected between 2002 and 2004 from children were tested for their susceptibility to penicillin, amoxycillin, erythromycin, clarythromycin and clindamycin. The erythromycin resistant isolates were further studied for their genetic mech...
Gespeichert in:
| Veröffentlicht in: | Pathologie biologie (Paris) 2004-10, Vol.52 (8), p.489-492 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | fre |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 492 |
|---|---|
| container_issue | 8 |
| container_start_page | 489 |
| container_title | Pathologie biologie (Paris) |
| container_volume | 52 |
| creator | Mariani-Kurkdjian, P Doit, C Deforche, D Brahimi, N Francois, M Van den Abbeele, T Bingen, E |
| description | A total of 206 recent throat isolates of Streptococcus pyogenes collected between 2002 and 2004 from children were tested for their susceptibility to penicillin, amoxycillin, erythromycin, clarythromycin and clindamycin. The erythromycin resistant isolates were further studied for their genetic mechanism of resistance by means of PCR. In all, 14.5% of the strains were erythromycin resistant and 13.5 and 1% expressed the constitutive MLS(B) and M resistance phenotypes and harbored the ermB and mef A genes respectively. |
| doi_str_mv | 10.1016/j.patbio.2004.07.032 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_66951172</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>66951172</sourcerecordid><originalsourceid>FETCH-LOGICAL-p139t-f588eb6dd9daeeeb77270e7f5c901966b7e0979e345381ca6fe1c0c7995c3d6c3</originalsourceid><addsrcrecordid>eNo1kMFKxDAURbNQnHH0D0Syctea1zRJs5RhRoUBF-q6pOmrZGibmqSL-XuLjqsLl8Phcgm5A5YDA_l4zCeTGufzgrEyZypnvLgga8alziqAckWuYzwyBgpKuCIrEKUUhWJrUu8GDF84WqS-o4OxwfeuRRowupjMmOh7Cjglb721c6TTyS80RhpTMG6M1I10wtaZFJylywqHY_pt98Es1hty2Zk-4u05N-Rzv_vYvmSHt-fX7dMhm4DrlHWiqrCRbatbg4iNUss6VJ2wmoGWslHItNLIS8ErsEZ2CJZZpbWwvJWWb8jDn3cK_nvGmOrBRYt9b0b0c6yl1AJAFQt4fwbnZsC2noIbTDjV_5fwHwJbZWk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66951172</pqid></control><display><type>article</type><title>Emergence of macrolide resistant Streptococcus pyogenes strains in pediatric patients in France</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Mariani-Kurkdjian, P ; Doit, C ; Deforche, D ; Brahimi, N ; Francois, M ; Van den Abbeele, T ; Bingen, E</creator><creatorcontrib>Mariani-Kurkdjian, P ; Doit, C ; Deforche, D ; Brahimi, N ; Francois, M ; Van den Abbeele, T ; Bingen, E</creatorcontrib><description>A total of 206 recent throat isolates of Streptococcus pyogenes collected between 2002 and 2004 from children were tested for their susceptibility to penicillin, amoxycillin, erythromycin, clarythromycin and clindamycin. The erythromycin resistant isolates were further studied for their genetic mechanism of resistance by means of PCR. In all, 14.5% of the strains were erythromycin resistant and 13.5 and 1% expressed the constitutive MLS(B) and M resistance phenotypes and harbored the ermB and mef A genes respectively.</description><identifier>ISSN: 0369-8114</identifier><identifier>DOI: 10.1016/j.patbio.2004.07.032</identifier><identifier>PMID: 15465270</identifier><language>fre</language><publisher>France</publisher><subject>Anti-Bacterial Agents - pharmacology ; Child ; Clarithromycin - pharmacology ; Clindamycin - pharmacology ; Drug Resistance, Bacterial ; Erythromycin - pharmacology ; Erythromycin - therapeutic use ; France ; Humans ; Macrolides - pharmacology ; Macrolides - therapeutic use ; Penicillins - pharmacology ; Streptococcal Infections - drug therapy ; Streptococcal Infections - microbiology ; Streptococcus pyogenes - drug effects</subject><ispartof>Pathologie biologie (Paris), 2004-10, Vol.52 (8), p.489-492</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15465270$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mariani-Kurkdjian, P</creatorcontrib><creatorcontrib>Doit, C</creatorcontrib><creatorcontrib>Deforche, D</creatorcontrib><creatorcontrib>Brahimi, N</creatorcontrib><creatorcontrib>Francois, M</creatorcontrib><creatorcontrib>Van den Abbeele, T</creatorcontrib><creatorcontrib>Bingen, E</creatorcontrib><title>Emergence of macrolide resistant Streptococcus pyogenes strains in pediatric patients in France</title><title>Pathologie biologie (Paris)</title><addtitle>Pathol Biol (Paris)</addtitle><description>A total of 206 recent throat isolates of Streptococcus pyogenes collected between 2002 and 2004 from children were tested for their susceptibility to penicillin, amoxycillin, erythromycin, clarythromycin and clindamycin. The erythromycin resistant isolates were further studied for their genetic mechanism of resistance by means of PCR. In all, 14.5% of the strains were erythromycin resistant and 13.5 and 1% expressed the constitutive MLS(B) and M resistance phenotypes and harbored the ermB and mef A genes respectively.</description><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Child</subject><subject>Clarithromycin - pharmacology</subject><subject>Clindamycin - pharmacology</subject><subject>Drug Resistance, Bacterial</subject><subject>Erythromycin - pharmacology</subject><subject>Erythromycin - therapeutic use</subject><subject>France</subject><subject>Humans</subject><subject>Macrolides - pharmacology</subject><subject>Macrolides - therapeutic use</subject><subject>Penicillins - pharmacology</subject><subject>Streptococcal Infections - drug therapy</subject><subject>Streptococcal Infections - microbiology</subject><subject>Streptococcus pyogenes - drug effects</subject><issn>0369-8114</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kMFKxDAURbNQnHH0D0Syctea1zRJs5RhRoUBF-q6pOmrZGibmqSL-XuLjqsLl8Phcgm5A5YDA_l4zCeTGufzgrEyZypnvLgga8alziqAckWuYzwyBgpKuCIrEKUUhWJrUu8GDF84WqS-o4OxwfeuRRowupjMmOh7Cjglb721c6TTyS80RhpTMG6M1I10wtaZFJylywqHY_pt98Es1hty2Zk-4u05N-Rzv_vYvmSHt-fX7dMhm4DrlHWiqrCRbatbg4iNUss6VJ2wmoGWslHItNLIS8ErsEZ2CJZZpbWwvJWWb8jDn3cK_nvGmOrBRYt9b0b0c6yl1AJAFQt4fwbnZsC2noIbTDjV_5fwHwJbZWk</recordid><startdate>200410</startdate><enddate>200410</enddate><creator>Mariani-Kurkdjian, P</creator><creator>Doit, C</creator><creator>Deforche, D</creator><creator>Brahimi, N</creator><creator>Francois, M</creator><creator>Van den Abbeele, T</creator><creator>Bingen, E</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200410</creationdate><title>Emergence of macrolide resistant Streptococcus pyogenes strains in pediatric patients in France</title><author>Mariani-Kurkdjian, P ; Doit, C ; Deforche, D ; Brahimi, N ; Francois, M ; Van den Abbeele, T ; Bingen, E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p139t-f588eb6dd9daeeeb77270e7f5c901966b7e0979e345381ca6fe1c0c7995c3d6c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>fre</language><creationdate>2004</creationdate><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Child</topic><topic>Clarithromycin - pharmacology</topic><topic>Clindamycin - pharmacology</topic><topic>Drug Resistance, Bacterial</topic><topic>Erythromycin - pharmacology</topic><topic>Erythromycin - therapeutic use</topic><topic>France</topic><topic>Humans</topic><topic>Macrolides - pharmacology</topic><topic>Macrolides - therapeutic use</topic><topic>Penicillins - pharmacology</topic><topic>Streptococcal Infections - drug therapy</topic><topic>Streptococcal Infections - microbiology</topic><topic>Streptococcus pyogenes - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mariani-Kurkdjian, P</creatorcontrib><creatorcontrib>Doit, C</creatorcontrib><creatorcontrib>Deforche, D</creatorcontrib><creatorcontrib>Brahimi, N</creatorcontrib><creatorcontrib>Francois, M</creatorcontrib><creatorcontrib>Van den Abbeele, T</creatorcontrib><creatorcontrib>Bingen, E</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Pathologie biologie (Paris)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mariani-Kurkdjian, P</au><au>Doit, C</au><au>Deforche, D</au><au>Brahimi, N</au><au>Francois, M</au><au>Van den Abbeele, T</au><au>Bingen, E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Emergence of macrolide resistant Streptococcus pyogenes strains in pediatric patients in France</atitle><jtitle>Pathologie biologie (Paris)</jtitle><addtitle>Pathol Biol (Paris)</addtitle><date>2004-10</date><risdate>2004</risdate><volume>52</volume><issue>8</issue><spage>489</spage><epage>492</epage><pages>489-492</pages><issn>0369-8114</issn><abstract>A total of 206 recent throat isolates of Streptococcus pyogenes collected between 2002 and 2004 from children were tested for their susceptibility to penicillin, amoxycillin, erythromycin, clarythromycin and clindamycin. The erythromycin resistant isolates were further studied for their genetic mechanism of resistance by means of PCR. In all, 14.5% of the strains were erythromycin resistant and 13.5 and 1% expressed the constitutive MLS(B) and M resistance phenotypes and harbored the ermB and mef A genes respectively.</abstract><cop>France</cop><pmid>15465270</pmid><doi>10.1016/j.patbio.2004.07.032</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0369-8114 |
| ispartof | Pathologie biologie (Paris), 2004-10, Vol.52 (8), p.489-492 |
| issn | 0369-8114 |
| language | fre |
| recordid | cdi_proquest_miscellaneous_66951172 |
| source | MEDLINE; Access via ScienceDirect (Elsevier) |
| subjects | Anti-Bacterial Agents - pharmacology Child Clarithromycin - pharmacology Clindamycin - pharmacology Drug Resistance, Bacterial Erythromycin - pharmacology Erythromycin - therapeutic use France Humans Macrolides - pharmacology Macrolides - therapeutic use Penicillins - pharmacology Streptococcal Infections - drug therapy Streptococcal Infections - microbiology Streptococcus pyogenes - drug effects |
| title | Emergence of macrolide resistant Streptococcus pyogenes strains in pediatric patients in France |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T20%3A04%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Emergence%20of%20macrolide%20resistant%20Streptococcus%20pyogenes%20strains%20in%20pediatric%20patients%20in%20France&rft.jtitle=Pathologie%20biologie%20(Paris)&rft.au=Mariani-Kurkdjian,%20P&rft.date=2004-10&rft.volume=52&rft.issue=8&rft.spage=489&rft.epage=492&rft.pages=489-492&rft.issn=0369-8114&rft_id=info:doi/10.1016/j.patbio.2004.07.032&rft_dat=%3Cproquest_pubme%3E66951172%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=66951172&rft_id=info:pmid/15465270&rfr_iscdi=true |